Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: A retrospective case series.

被引：0
|
作者：
Chamberlain, Marc C.
Kim, Bryan T.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e13538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13538
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
    D A Reardon
    J E Herndon
    K B Peters
    A Desjardins
    A Coan
    E Lou
    A L Sumrall
    S Turner
    E S Lipp
    S Sathornsumetee
    J N Rich
    J H Sampson
    A H Friedman
    S T Boulton
    D D Bigner
    H S Friedman
    J J Vredenburgh
    British Journal of Cancer, 2012, 107 : 1481 - 1487
  • [42] Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series
    Lou, Emil
    Sumrall, Ashley L.
    Turner, Scott
    Peters, Katherine B.
    Desjardins, Annick
    Vredenburgh, James J.
    McLendon, Roger E.
    Herndon, James E., II
    McSherry, Frances
    Norfleet, Julie
    Friedman, Henry S.
    Reardon, David A.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (01) : 63 - 70
  • [43] EVIDENCE OF T CELL ACTIVATION AND INTRATUMORAL NIVOLUMAB-PRESENCE IN GLIOBLASTOMA PATIENTS TREATED WITH NIVOLUMAB AND BEVACIZUMAB
    Skadborg, Signe
    Maarup, Simone
    Draghi, Arianna
    Borch, Annie
    Svane, Inge Marie
    Hasselbalch, Benedikte
    Poulsen, Hans
    Lassen, Ulrik
    Hadrup, Sine
    NEURO-ONCOLOGY, 2021, 23 : 55 - 55
  • [44] A RETROSPECTIVE REVIEW OF PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) TREATED WITH BEVACIZUMAB (AVASTIN), LOMUSTINE (CCNU) AND SIROLIMUS (RAPAMUNE)
    Ranjan, Tulika
    Peters, Katherine
    Vlahovic, Gordana
    Friedman, Henry
    Desjardins, Annick
    NEURO-ONCOLOGY, 2013, 15 : 127 - 127
  • [45] RETROSPECTIVE STUDY OF USING CARMUSTINE OR LOMUSTINE WITH BEVACIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS WHO HAVE FAILED PRIOR
    Rahman, Rifaquat
    Hempfling, Kelly
    Norden, Andrew
    Reardon, David A.
    Nayak, Lakshmi
    Rinne, Mikael
    Doherty, Lisa
    Ruland, Sandra
    Rai, Arun
    Rifenburg, Jennifer
    LaFrankie, Debra
    Wen, Patrick
    Lee, Eudocia
    NEURO-ONCOLOGY, 2013, 15 : 126 - 127
  • [46] BEVACIZUMAB AND IRINOTECAN IN PATIENTS WITH RECURRENT GLIOBLASTOMA: RESULTS OF A RETROSPECTIVE COHORT IN COMPLEJO HOSPITALARIO DE NAVARRA, SPAIN
    Teijeira, Lucia
    Gil-Arnaiz, Irene
    Hernandez-Marin, Berta
    Martinez-Aguillo, Maite
    de la Cruz Sanchez, Susana
    Viudez, Antonio
    Hernandez-Garcia, Irene
    Jose Lecumberri, Maria
    Grandez, Rosana
    Fernandez de Lascoiti, Angela
    Vera Garcia, Ruth
    NEURO-ONCOLOGY, 2013, 15 : 73 - 73
  • [47] Neuraxis imaging in leptomeningeal metastasis: A retrospective case series.
    Chamberlain, Marc C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] A RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA (GBM)
    Ahluwalia, Manmeet
    Fallah, Jaleh
    Peereboom, David
    Schilero, Cathy
    Ali, Assad
    Forst, Deborah
    Wong, Eric
    Wen, Patrick
    Reardon, David
    NEURO-ONCOLOGY, 2019, 21 : 220 - 220
  • [49] A retrospective single institutional analysis of bevacizumab and chemotherapy versus non-bevacizumab treatments for recurrent glioblastoma
    Nghiemphu, P.
    Graham, C.
    Liu, W.
    Than, T.
    Lai, A.
    Green, R.
    Elashoff, R. M.
    Cloughesy, T. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] RECURRENT ANAPLASTIC MENINGIOMA TREATED WITH BEVACIZUMAB: CASE SERIES
    Matienzo, Lovelyn
    Batara, Julette
    Torcuator, Roy
    NEURO-ONCOLOGY, 2012, 14 : 58 - 58
12345